Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Neoplasms of the CNS

Free Subscription 30.03.2026 1 AJNR Am J Neuroradiol 1 BMC Cancer 1 Br J Neurosurg 2 Cancer Res 3 Childs Nerv Syst 1 Clin Cancer Res 1 Int J Cancer 7 J Neurooncol 1 J Neuropathol Exp Neurol 1 J Neurosurg 1 J Nucl Med 2 Neuro Oncol 3 Oncogene 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. ELMOUJARKACH E, Sharbatdaran A, Pontolillo L, Jean J, et al
   Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases.
   AJNR Am J Neuroradiol. 2026 Mar 26:ajnr.A9316. doi: 10.3174/ajnr.A9316.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. XU Z, Yuan S, Li X, Chen H, et al
   ZCCHC4 drives glioma progression and serves as a prognostic biomarker.
   BMC Cancer. 2026 Mar 23. doi: 10.1186/s12885-026-15881.
   PubMed        
   
   

   
   Br J Neurosurg

3. CLERKIN J, Healy V, Horan J, Caird J, et al
   Pineal glioblastoma: a case series and updated literature review.
   Br J Neurosurg. 2026 Mar 25:1-9. doi: 10.1080/02688697.2026.2647948.
   PubMed         Abstract available
   
   

   
   Cancer Res

4. WANG C, Sun T, He Y, Yu M, et al
   A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations.
   Cancer Res. 2026 Mar 26. doi: 10.1158/0008-5472.CAN-25-2679.
   PubMed         Abstract available
   
   
5. ALVARO-ESPINOSA L, Marquez-Galera A, Priego N, Garcia-Calvo V, et al
   MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and are Clinically Relevant Across Central Nervous System Disorders.
   Cancer Res. 2026 Mar 24. doi: 10.1158/0008-5472.CAN-25-4018.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. ERBAGCI A, Akkurt TS, Atalay B, Gurbuz MS, et al
   A PMS2-deficient pediatric high-grade glioma with PI3K-pathway mutations and adjacent developmental venous anomaly suggestive of CMMRD.
   Childs Nerv Syst. 2026;42:135.
   PubMed         Abstract available
   
   
7. MAHAJAN KR, Bhaskar S, Agrawal M, Masne R, et al
   Reverse brain herniation following CSF diversion in a 2-year-old child-case report and review of literature.
   Childs Nerv Syst. 2026;42:132.
   PubMed         Abstract available
   
   
8. SUDEVAN KJ, Konar SK, Shukla DP, Sadashiva N, et al
   Endoscopic transnasal surgery for pituitary neuroendocrine tumors (Pit-NETs) in children and young adolescents (CYP) - clinical profile, outcomes and sino-nasal quality of life - an Institutional Experience.
   Childs Nerv Syst. 2026;42:130.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

9. BUTT OH, Singhal K, Luo J, Rettig MP, et al
   NT-I7, a long-acting interleukin-7, increases lymphocyte counts and induces CD8+ T cell clonotype expansion in patients with newly diagnosed high-grade gliomas.
   Clin Cancer Res. 2026 Mar 25. doi: 10.1158/1078-0432.CCR-25-2953.
   PubMed         Abstract available
   
   

   
   Int J Cancer

10. ACKER F, Wenger K, Reck M, Waller CF, et al
    Prediction of the individual risk for the development of brain metastases in patients with non-oncogene-addicted non-small cell lung cancer: Real-world data from the German prospective CRISP registry (AIO-TRK-0315).
    Int J Cancer. 2026 Mar 23. doi: 10.1002/ijc.70456.
    PubMed         Abstract available
    
    

    
    J Neurooncol

11. BANSON M, Lear G, Darko K, Moor RSF, et al
    Leveraging biometric data for meaningful outcome assessments in the care of patients with brain tumors: a systematic review.
    J Neurooncol. 2026;177:66.
    PubMed        
    
    
12. DELBRIDGE C, Hou HX, Hielscher T, Wiestler B, et al
    Prognostic impact of radiotherapy timing in WHO grade 2 and 3 meningiomas utilizing an integrated molecular-morphologic classification.
    J Neurooncol. 2026;177:67.
    PubMed         Abstract available
    
    
13. AYDIN HA, Keskin E, Kalayci M
    Perioperative risk stratification after resection of brain metastases: internal development and validation of the dominant lesion surgery score in a 20-year single-center cohort.
    J Neurooncol. 2026;177:69.
    PubMed         Abstract available
    
    
14. MULLER S, Hendricks A, Uttinger K, Kostatin M, et al
    Brain metastases from colorectal cancer - a retrospective dual center study.
    J Neurooncol. 2026;177:71.
    PubMed         Abstract available
    
    
15. IZHAR M, Kattaa AH, Hori YS, Lam FC, et al
    Treatment outcomes of stereotactic radiosurgery for sarcoma brain metastases-systematic review.
    J Neurooncol. 2026;177:70.
    PubMed        
    
    
16. REUTER J, Werfel T, Ruhle A, Wurschi G, et al
    Regret concerning treatment decisions in patients with primary or secondary brain tumors - a cross-sectional exploratory bicentric analysis.
    J Neurooncol. 2026;177:74.
    PubMed         Abstract available
    
    
17. SANKAR BS, Johnson D, Boasiako PA, Vargas LO, et al
    Cerebrospinal fluid ctDNA as a prognostic and disease-activity biomarker in leptomeningeal metastases: systematic review, meta-analysis, and implications for CSF-guided care.
    J Neurooncol. 2026;177:75.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

18. KAHR J, Diaz-Peregrino R, Sandalcioglu IE, John P, et al
    RagC and Map4K3 deficiency in high-grade gliomas drives proliferation and modulates mTORC1-dependent cellular functions.
    J Neuropathol Exp Neurol. 2026 Mar 22:nlag010. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

19. NG S, Giampiccolo D, Moritz-Gasser S, Herbet G, et al
    Tracking evolving cortical plasticity in recurrent low-grade glioma patients: a prospective pilot study based on serial intraoperative awake direct electrostimulation and transcranial magnetic stimulation mappings.
    J Neurosurg. 2026 Mar 20:1-11. doi: 10.3171/2025.10.JNS251874.
    PubMed         Abstract available
    
    

    
    J Nucl Med

20. GEENS W, Buyck F, Raes L, Schwarze JK, et al
    Prognostic Value of O-(2-(18)F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 26:jnumed.125.270727. doi: 10.2967/jnumed.125.270727.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

21. WRIGHT E, Billups C, Rush S, Li Y, et al
    Cumulative dose of chemotherapy and survival outcomes in children with average risk medulloblastoma treated on Children's Oncology Group study ACNS0331.
    Neuro Oncol. 2026 Mar 26:noag064. doi: 10.1093.
    PubMed         Abstract available
    
    
22. DUNN GP, Yu KKH, Krucoff MO, Bojanowski-Hoang K, et al
    Recent progress and future directions to advance glioblastoma research: A consensus perspective from the 2024 Christopher Davidson Forum.
    Neuro Oncol. 2026 Mar 23:noag043. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Oncogene

23. KIM JK, Park MG, Ham SW, Yoon S, et al
    Loss of ABCA3 disrupts lipid balance and leads to AMPK-dependent suppression of SREBP1 in glioblastoma stem cells.
    Oncogene. 2026 Mar 25. doi: 10.1038/s41388-026-03736.
    PubMed         Abstract available
    
    
24. YAO L, Gao H, Su Z, Zhao G, et al
    PAK4 functions as an immune suppressor by reprogramming the phosphatidylcholine metabolism of CD8 + T cells within the glioblastoma tumor microenvironment.
    Oncogene. 2026 Mar 23. doi: 10.1038/s41388-026-03734.
    PubMed         Abstract available
    
    
25. XIE Y, Wu Z, Ji C, Zhang Y, et al
    CDK8 phosphorylates SOX2 to maintain stemness of pituitary adenoma.
    Oncogene. 2026;45:1161-1174.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

26. POLARA R, Gliddon BL, Ganesan R, Davies LT, et al
    CD47 stabilizes ROBO2 to regulate glioblastoma progression by preventing ITCH-mediated ubiquitination.
    Proc Natl Acad Sci U S A. 2026;123:e2602460123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum